Data from ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell–Dependent Tumor Immunity and Synergizes with PD-1 Blockade
Authors:
- Hampus AnderssonHAHampus Andersson
- Ida UddbäckIUIda Uddbäck
- Tova HermodssonTHTova Hermodsson
- Mona CelanderMCMona Celander
- Amulya Krishna ShettyASAmulya Krishna Shetty
- Lill LjungLLLill Ljung
- Anneli NilssonANAnneli Nilsson
- Anette SundstedtASAnette Sundstedt
- Laura von SchantzLSLaura von Schantz
- Laura A. VarasLVLaura A. Varas
- Mattias LevinMLMattias Levin
- Anna SällASAnna Säll
Open Access
- 2 December 2025
- other
- Published by American Association for Cancer Research (AACR)